Apimeds Pharmaceuticals US, Inc.

Apimeds Pharmaceuticals US, Inc. financial statements

Apimeds Pharmaceuticals US, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 6M10-K
Cash and equivalentsUSD 144.6K10-Q
Total debtUSD 7.76MEODHD

Apimeds Pharmaceuticals US, Inc. financials on 6ix · Apimeds Pharmaceuticals US, Inc. on 6ix